Dr. Zeynep Madak-Erdogan, from UIUC, and Yosef Landesman, from Karyopharm Therapeutics, have developed a new combination therapy for the treatment of breast cancer. This combination therapy may be used to improve the treatment of breast cancers by co-targeting different pathways responsible for cancer proliferation and cell line viability. The specific therapy could help reduce recurrence of breast cancer.